Dechra Pharmaceuticals Ltd

GB

Health Care

98 ₽

Current price

Strong sell
98 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    1153 / 1328

  • Position in country

    1739 / 1912

  • Return on Assets, %

    -1.6

    -2.7

  • Net income margin, %

    -13.2

    2.8

  • EBITDA margin, %

    22.4

    10.8

  • Debt to Equity, %

    66.8

    19.2

  • Intangible assets and goodwill, %

    58.7

    3.6

  • Revenue CAGR 3Y, %

    13.9

    8.5

  • Revenue Y, % chg

    7

    0.5

  • P/BV

    -52.6

    1.5

  • EV/EBITDA

    27.3

    7.4

  • Dividend Yield, %

    1.1

    1.7

  • Dividend Ex Date

    2023-03-09

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • AstraZeneca PLC

    00%

  • Indivior PLC

    00%

  • GSK plc

    00%

  • Verona Pharma PLC

    00%

  • Eli Lilly and Co

    00%

  • Hikma Pharmaceuticals PLC

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

  • Dechra Pharmaceuticals Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United Kingdom

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    5564.3

  • Ticker

    DPHAY.PK

  • ISIN

    US2434351043

  • IPO date

  • Availability on Russian exchanges

    No

  • Reporting for

    2023-10-17

  • Date fact. publication of reports

    2023-06-30

Company Description

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Dechra Veterinary Products International and Dechra Pharmaceuticals Manufacturing. It manufactures and markets companion animal, equine, food producing animal products and nutrition. The North American (NA) Pharmaceuticals segment consists of Dechra Veterinary Products US, Dechra Produtas Veterinarios (Mexico) and Dechra Veterinary Products Canada, which sells companion animal, equine and food producing animal products. The segment also includes its manufacturing units based in Melbourne, Florida and Fort Worth, Texas.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: